Rein Therapeutics (RNTX) Q4 2025 Earnings

14NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.28
-0.26
-0.23
-0.21

Details

Expected EPS
-0.24
Actual EPS
-0.21
Surprise EPS
0.03
Surprise Percent
+12.5%

Description

Rein Therapeutics (RNTX) has reported earnings of -0.21 per share for Q4 2025.

0 Comments

Share your thoughts